We are live on ! Find out more
LYFE

2ndVote Life Neutral Plus ETF

Delisted

LYFE was delisted on the 3rd of August, 2023.

13 hedge funds and large institutions have $1.46M invested in 2ndVote Life Neutral Plus ETF in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

86% more funds holding

Funds holding: 713 (+6)

33% more capital invested

Capital invested by funds: $1.1M → $1.46M (+$362K)

Holders
13
Holders Change
+6
Holders Change %
+85.71%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
3
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

LYFE Hedge Fund Activity: Q4 2022 in Review

13 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in 2ndVote Life Neutral Plus ETF (LYFE) for Q4 2022, worth a combined $1.46M — up 33% from $1.1M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new LYFE positions and 0 closed out — a net gain of 6 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $314K. The largest seller was Citadel Advisors, cutting an estimated $195K.

  • 13 institutional investors held 2ndVote Life Neutral Plus ETF (LYFE) as of Q4 2022, up from 7 in Q3 2022.
  • Funds reported $1.46M of 2ndVote Life Neutral Plus ETF stock for Q4 2022, up 33% quarter-over-quarter.
  • 6 funds opened new 2ndVote Life Neutral Plus ETF positions in Q4 2022 and 0 closed out, a net change of +6 holders.
  • The largest 2ndVote Life Neutral Plus ETF buyer in Q4 2022 was Tower Research Capital (TRC), an estimated $314K added.
  • The largest 2ndVote Life Neutral Plus ETF seller in Q4 2022 was Citadel Advisors, an estimated $195K sold.

Based on aggregated 13F filings for Q4 2022.